Safety and Tolerability of COVID-19 Vaccine in Children With Epilepsy: A Prospective, Multicenter Study

Area of Science:

• Pediatrics
• Neurology
• Immunology

Background:

• Epilepsy affects children globally, necessitating careful consideration of vaccination protocols.
• The coronavirus disease 2019 (COVID-19) pandemic posed unique challenges for vulnerable populations, including children with epilepsy.
• Understanding the safety and efficacy of COVID-19 vaccines in this demographic is crucial for public health strategies.

Purpose of the Study:

• To investigate the impact of COVID-19 vaccination on seizure activity in children with epilepsy.
• To assess the incidence and types of adverse events following COVID-19 vaccination in pediatric epilepsy patients.
• To evaluate the overall risk-benefit profile of COVID-19 vaccination for children with epilepsy.

Main Methods:

• A multicenter prospective survey was conducted using anonymous questionnaires.
• The study included 224 children under 18 years old with epilepsy from six cities in Shandong Province.
• Data collection focused on adverse events and seizure frequency post-vaccination.

Main Results:

• Fifty out of 224 children experienced general adverse events, most commonly injection site pain, muscle soreness, and headache.
• No severe adverse events were reported following COVID-19 vaccination.
• The risk of seizures decreased in children seizure-free for over six months prior to vaccination, with no significant change in overall seizure frequency.

Conclusions:

• COVID-19 vaccination is safe for children with epilepsy, with generally mild and transient adverse events.
• The benefits of COVID-19 vaccination in preventing severe illness and complications significantly outweigh the minimal risks observed in children with epilepsy.
• Vaccination should be encouraged in children with epilepsy to protect them from COVID-19.